{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:10:03Z","timestamp":1789899003910,"version":"4.0.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.trsl.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T18:00:24Z","timestamp":1458669624000},"page":"77-85.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Mastocytosis in adulthood and neuropsychiatric disorders"],"prefix":"10.1016","volume":"174","author":[{"given":"Sophie","family":"Georgin-Lavialle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.03.013_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Akin","year":"2014","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.trsl.2016.03.013_bib2","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients' perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.03.013_bib3","doi-asserted-by":"crossref","first-page":"e26375","DOI":"10.1371\/journal.pone.0026375","article-title":"Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy","volume":"6","author":"Moura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.03.013_bib4","doi-asserted-by":"crossref","first-page":"e39468","DOI":"10.1371\/journal.pone.0039468","article-title":"Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression","volume":"7","author":"Moura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.03.013_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","article-title":"Mastocytosis: mediator-related signs and symptoms","volume":"127","author":"Castells","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib6","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/0333102411421683","article-title":"Primary headache syndromes in systemic mastocytosis","volume":"31","author":"Smith","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.trsl.2016.03.013_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clineuro.2011.05.002","article-title":"Neurologic symptoms and diagnosis in adults with mast cell disease","volume":"113","author":"Smith","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.trsl.2016.03.013_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2169\/internalmedicine.33.23","article-title":"Sequential magnetic resonance features of encephalopathy induced by systemic mastocytosis","volume":"33","author":"Tajima","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.revmed.2005.06.004","volume":"26","author":"Larroche","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.trsl.2016.03.013_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1346-8138.2001.tb00009.x","article-title":"A case of mastocytosis with chorea","volume":"28","author":"Kanekura","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.trsl.2016.03.013_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002770000271","article-title":"Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage","volume":"80","author":"Jost","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.trsl.2016.03.013_bib12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/jnnp.51.11.1457-a","article-title":"Chorea: a new manifestation of mastocytosis","volume":"51","author":"Iriarte","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0303-8467(92)90100-H","article-title":"Generalized mastocytosis and neurological complications in a 71-year-old patient","volume":"94","author":"Frijns","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.trsl.2016.03.013_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.wnl.0000168897.35545.61","article-title":"Systemic mastocytosis: a potential neurologic emergency","volume":"65","author":"Boncoraglio","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2016.03.013_bib15","first-page":"1345","volume":"79","author":"Arnould","year":"1971","journal-title":"Presse M\u00e9dicale"},{"key":"10.1016\/j.trsl.2016.03.013_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.trsl.2016.03.013_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00006842-198607000-00006","article-title":"Mixed organic brain syndrome as a manifestation of systemic mastocytosis","volume":"48","author":"Rogers","year":"1986","journal-title":"Psychosom Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients","volume":"119","author":"Casassus","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2016.03.013_bib19","first-page":"125","volume":"19","author":"Lortholary","year":"1990","journal-title":"Presse M\u00e9dicale Paris Fr 1983"},{"key":"10.1016\/j.trsl.2016.03.013_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM197908303010903","article-title":"Oral disodium cromoglycate in the treatment of systemic mastocytosis","volume":"301","author":"Soter","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2003.11.003","article-title":"Dimensional structure of the Hamilton Depression Rating Scale in patients with obsessive-compulsive disorder","volume":"125","author":"Moritz","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0269216309106978","article-title":"Depression assessment and classification in palliative cancer patients: a systematic literature review","volume":"23","author":"Wasteson","year":"2009","journal-title":"Palliat Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.nmd.0000154840.63529.5d","article-title":"Is the cutoff to define remission on the Hamilton Rating Scale for depression too high?","volume":"193","author":"Zimmerman","year":"2005","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.trsl.2016.03.013_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.trsl.2016.03.013_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbi.2013.07.009","article-title":"Leukocyte telomere length in mastocytosis: correlations with depression and perceived stress","volume":"35","author":"Georgin-Lavialle","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.trsl.2016.03.013_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.41.7.1006","article-title":"Mild cognitive impairment in the elderly: predictors of dementia","volume":"41","author":"Flicker","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2016.03.013_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2016.03.013_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3233\/JAD-2011-111550","article-title":"Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study","volume":"28","author":"Creavin","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.trsl.2016.03.013_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jalz.2011.02.008","article-title":"Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors","volume":"8","author":"Peltz","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.trsl.2016.03.013_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2016.03.013_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00019052-200306000-00006","article-title":"Cognitive dysfunction in multiple sclerosis: a review of recent developments","volume":"16","author":"Bobholz","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.trsl.2016.03.013_bib32","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/sj.npp.1301362","article-title":"Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy","volume":"32","author":"Capuron","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.trsl.2016.03.013_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","article-title":"The neuroimmune basis of fatigue","volume":"37","author":"Dantzer","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.trsl.2016.03.013_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.trsl.2016.03.013_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2007.07.034","article-title":"Brain mast cell relationship to neurovasculature during development","volume":"1171","author":"Khalil","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib36","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.27.9.878","article-title":"Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain","volume":"27","author":"Edvinsson","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2016.03.013_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.194.1.71","article-title":"Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs","volume":"194","author":"Matsumoto","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(84)90291-9","article-title":"Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymmetry","volume":"323","author":"Goldschmidt","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pain.2004.12.002","article-title":"Unilateral spinal nerve ligation leads to an asymmetrical distribution of mast cells in the thalamus of female but not male mice","volume":"114","author":"Taiwo","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2016.03.013_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000235470","article-title":"Endogenous regulation of rat brain mast cell serotonin release","volume":"95","author":"Marathias","year":"1991","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u201cbrain-skin connection.\u201d","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/210756b0","article-title":"Mast cells in the central nervous system","volume":"210","author":"Campbell","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.03.013_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/brbi.1998.0505","article-title":"Increased number of mast cells in the central nervous system of adult male mice following chronic subordination stress","volume":"12","author":"Cirulli","year":"1998","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.trsl.2016.03.013_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2008.10.001","article-title":"Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis","volume":"33","author":"Ng","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.trsl.2016.03.013_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2004.11.006","article-title":"The role of mast cells in migraine pathophysiology","volume":"49","author":"Theoharides","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.trsl.2016.03.013_bib46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/BF00993271","article-title":"Interactions of mast cells with the nervous system\u2014recent advances","volume":"17","author":"Johnson","year":"1992","journal-title":"Neurochem Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000234197","article-title":"The role of mast cells in inflammatory processes: evidence for nerve\/mast cell interactions","volume":"82","author":"Bienenstock","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.12170","article-title":"Mast cells, glia and neuroinflammation: partners in crime?","volume":"141","author":"Skaper","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2016.03.013_bib49","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/j.1460-9568.2005.04429.x","article-title":"Central nervous system neurons acquire mast cell products via transgranulation","volume":"22","author":"Wilhelm","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.trsl.2016.03.013_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","article-title":"Mast cell degranulation activates a pain pathway underlying migraine headache","volume":"130","author":"Levy","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2016.03.013_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(96)00102-6","article-title":"The mast cells of the multiple sclerosis brain","volume":"70","author":"Ibrahim","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.0305-1846.2001.00331.x","article-title":"Mast cells and multiple sclerosis: a quantitative analysis","volume":"27","author":"Kr\u00fcger","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.trsl.2016.03.013_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ana.410370112","article-title":"Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients","volume":"37","author":"Rozniecki","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2016.03.013_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneuroim.2008.01.017","article-title":"Mast cell transcripts are increased within and outside multiple sclerosis lesions","volume":"195","author":"Couturier","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib56","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect","volume":"136","author":"Theoharides","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2016.03.013_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004714-200204000-00001","article-title":"Mast cells and stress\u2014a psychoneuroimmunological perspective","volume":"22","author":"Theoharides","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.trsl.2016.03.013_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.10.041","article-title":"Critical role of mast cells in inflammatory diseases and the effect of acute stress","volume":"146","author":"Theoharides","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib59","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2741\/2174","article-title":"Corticotropin-releasing hormone and the blood-brain-barrier","volume":"12","author":"Theoharides","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.trsl.2016.03.013_bib60","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0079-6123(02)41102-8","article-title":"GnRH, brain mast cells and behavior","volume":"141","author":"Silverman","year":"2002","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib62","doi-asserted-by":"crossref","first-page":"18053","DOI":"10.1073\/pnas.0809479105","article-title":"Brain mast cells link the immune system to anxiety-like behavior","volume":"105","author":"Nautiyal","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.03.013_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(00)03026-2","article-title":"Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells","volume":"888","author":"Esposito","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2016.03.013_bib64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress","volume":"303","author":"Esposito","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2016.03.013_bib65","doi-asserted-by":"crossref","DOI":"10.1007\/BF02007774","article-title":"Effect of isolation stress on brain mast cells and brain histamine levels in rats","volume":"41","author":"Bugajski","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.trsl.2016.03.013_bib66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1081-1206(10)60717-X","article-title":"Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis","volume":"98","author":"Kalogeromitros","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib67","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1440-1746.1998.tb00558.x","article-title":"Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome","volume":"13","author":"Gui","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2016.03.013_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.2911721","article-title":"Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II","volume":"243","author":"MacQueen","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.03.013_bib69","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1346-8138.2010.01045.x","article-title":"Effects of stress memory by fear conditioning on nerve-mast cell circuit in skin","volume":"38","author":"Kumagai","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.trsl.2016.03.013_bib70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0031-9384(94)90066-3","article-title":"Pavlovian conditioning of nasal tryptase release in human subjects with allergic rhinitis","volume":"55","author":"Gauci","year":"1994","journal-title":"Physiol Behav"},{"key":"10.1016\/j.trsl.2016.03.013_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2012.08.013","article-title":"Mast cells and inflammation","volume":"80","author":"Frenzel","year":"2013","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"10.1016\/j.trsl.2016.03.013_bib72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0269881107081526","article-title":"Histamine H1-receptor blockade in humans affects psychomotor performance but not memory","volume":"22","author":"van Ruitenbeek","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.trsl.2016.03.013_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-007-0814-z","article-title":"Effects of sedative and non-sedative H1 antagonists on cognitive tasks: behavioral and near-infrared spectroscopy (NIRS) examinations","volume":"194","author":"Tsujii","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.trsl.2016.03.013_bib74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(02)02276-2","article-title":"Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain","volume":"72","author":"Tashiro","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2016.03.013_bib75","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1111\/j.1460-9568.2012.08138.x","article-title":"Serotonin of mast cell origin contributes to hippocampal function","volume":"36","author":"Nautiyal","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.trsl.2016.03.013_bib76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaci.2006.09.003","article-title":"Human mast cells are capable of serotonin synthesis and release","volume":"119","author":"Kushnir-Sukhov","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib77","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2362.2008.02047.x","article-title":"Clinical correlates of blood serotonin levels in patients with mastocytosis","volume":"38","author":"Kushnir-Sukhov","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2016.03.013_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2015.216","article-title":"Mast cells involvement in inflammation pathways linked to depression: evidence in mastocytosis","author":"Georgin-Lavialle","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2016.03.013_bib80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.trsl.2016.03.013_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib82","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","article-title":"Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression","volume":"65","author":"Raison","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib83","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1248\/bpb.b13-00150","article-title":"Drinkable preparation of Theracurmin exhibits high absorption efficiency\u2014a single-dose, double-blind, 4-way crossover study","volume":"36","author":"Morimoto","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.trsl.2016.03.013_bib84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-4159.2011.07414.x","article-title":"Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery","volume":"119","author":"Forrest","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.trsl.2016.03.013_bib85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.revmed.2008.01.025","volume":"30","author":"Georgin-Lavialle","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.trsl.2016.03.013_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbi.2012.10.013","article-title":"A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation","volume":"27","author":"Rosenkranz","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.trsl.2016.03.013_bib87","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbi.2010.10.013","article-title":"Citalopram reduces endotoxin-induced fatigue","volume":"25","author":"Hannestad","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.trsl.2016.03.013_bib88","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.03.013_bib89","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.23931","article-title":"Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Pardanani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2016.03.013_bib90","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.trsl.2016.03.013_bib91","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.encep.2013.07.001","volume":"39","author":"Gaillard","year":"2013","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.trsl.2016.03.013_bib92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11910-005-0012-5","article-title":"Fatigue in multiple sclerosis: a rational approach to evaluation and treatment","volume":"5","author":"Rosenberg","year":"2005","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.trsl.2016.03.013_bib93","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.bp.107.037879","article-title":"Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations","volume":"191","author":"Hafizi","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib95","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCP.0b013e3182196e50","article-title":"Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome","volume":"31","author":"Clemons","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.trsl.2016.03.013_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/SHK.0b013e3182168d56","article-title":"Effects of the \u03b17 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans","volume":"36","author":"Kox","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.trsl.2016.03.013_bib97","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nri2566","article-title":"Reflex control of immunity","volume":"9","author":"Tracey","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.03.013_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.trsl.2016.03.013_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.encep.2013.09.001","volume":"40","author":"De Maricourt","year":"2014","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.trsl.2016.03.013_bib100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.03.013_bib101","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.trsl.2016.03.013_bib102","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2016.03.013_bib103","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.trsl.2016.03.013_bib104","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study","volume":"85","author":"Paul","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2016.03.013_bib105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00210-014-1061-6","article-title":"Neuroprotective effect of masitinib in rats with postischemic stroke","volume":"388","author":"Kocic","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T21:51:04Z","timestamp":1567720264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":105,"alternative-id":["S1931524416001055"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.03.013","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mastocytosis in adulthood and neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}